NeoGenomics

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.

6 past transactions

Inivata

Acquisition in 2021
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.

Trapelo Health

Acquisition in 2021
Trapelo Health is an Information Technology company focused on precision oncology. Trapelo is an innovative decision support platform that aligns the interests of providers, labs, and payors in the appropriate, scalable use of precision medicine - in real-time.

Inivata

Corporate Round in 2020
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients. Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.

Genoptix

Acquisition in 2018
As a pioneering force in oncology, Genoptix regularly participates in industry conferences to share their findings, discuss emerging solutions, and create meaningful connections to advance the community.

Clarient

Acquisition in 2015
Clarient is a leading provider of cancer diagnostic testing. They work with local pathologists and oncologists to bring the standard of care back into their community. They're dedicated to providing clarity to complex problems by using a number of technologies to help their clients diagnose cancer cases. They also provide them insight into what therapies will work best for these patients, and continue with follow-up and case monitoring.

Path Logic

Acquisition in 2014
Path Logic is recognized today as one of California's most innovative and rapidly growing anatomic pathology services providers. We are a full service anatomic pathology laboratory with a stellar reputation for accurate diagnostics, precise reporting, web-based information sharing, rapid turnaround of patient results, and personalized customer service.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.